Ghavami et al. [39] evaluated one genetic polymorphism located in the IL-27 gene, A964G, in patients with acute lymphoblastic leukemia (ALL) and demonstrated a higher risk to develop ALL for patients presenting the AG heterozygous genotype and G allele, a greater relapse rate and a worse therapeutic response for these patients. This evidence concerns the gene IL27 and acute lymphoblastic leukemia.